HDAC8-IN-13
Product Specifications
UNSPSC Description
HDAC8-IN-13 is a novel histone deacetylase 8 (HDAC8) inhibitor with antiparasitic activity. HDAC8-IN-13 can effectively inhibit the acetyl-L-lysine deacetylase activity of schistosomes, affecting the parasite's infectivity. HDAC8-IN-13 can induce apoptosis and cause the death of schistosome cells. Through a specific structural basis design, HDAC8-IN-13 exhibits reduced affinity for human HDACs, thereby enhancing its selectivity[1].
Target Antigen
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hdac8-in-13.html
Smiles
O=C(C1=CC=C(SCCC(N2)=O)C2=C1)NO
Molecular Weight
238.26
References & Citations
[1]Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-111027/HDAC8-IN-13-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-111027/
Clinical Information
No Development Reported
CAS Number
949792-00-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC231278L3V 200 µL
Sohlh2 (CCDC169-SOHLH2) (NM_001198910) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details